FDA clears EOS Micro Dose for pediatric imaging

EOS Imaging has received clearance from the Food and Drug Administration for its Micro Dose feature for pediatric imaging.

The EOS Imaging system is a low-dose 3-D imaging system that is able to scan children while they are standing up, allowing physicians to get a more accurate view of the spine and lower limbs.

According to EOS, initial results for Micro Dose show that it produces dose levels that are equivalent to a week’s worth of naturally occurring background radiation in pediatric patients receiving 2D and 3D follow up exams.

“The reduction of radiation exposure during orthopedic imaging exams remains a foremost concern among radiologists, orthopedic surgeons and patients,” said Marie Meynadier, CEO of EOS Imaging, in a statement. “The Micro Dose solution is a giant step forward and is in full accordance with the ALARA (As Low As Reasonably Achievable) principle.”